The 2011 Leading Pharmaceutical Companies R&D Expenditures and Major Programs

Complete report $1,850.  Individual company assessments $250.

For each company, the report provides:

• Annual R&D budget.
• Research facilities and staff.
• New technologies, drugs, and indications in development, including their phase and anticipated introduction dates.

         -   Abbott
         -   AstraZeneca
         -   Eli Lilly
         -   GlaxoSmithKline
         -   Johnson & Johnson
         -   Merck
         -   Novartis
         -   Pfizer
         -   Roche
         -   Sanofi-Aventis 

Contains 160 pages